Limiting access to non–vitamin K antagonist oral anticoagulants through step therapy and prior authorization may exacerbate current underuse of anticoagulants and increase the risk of stroke in patients with newly diagnosed atrial fibrillation.
Bo Zhou, PhD
Advertisement
Articles by Bo Zhou, PhD
Advertisement
Latest Updated Articles
- Formulary Restrictions and Stroke Risk in Patients With Atrial Fibrillation
Published: August 4th 2022 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
3
Teclistamab for R/R MM Effective and Safe When Administered in a Community Setting
4
Contributor: Medication Adherence as a Journey—A Year-Round Strategy for Medicare Advantage Success
5
